Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2. - Wikidata - wikimedia - TriplyDB

Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2.

Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2.

http://www.wikidata.org/entity/Q36620845

about

Optimizing the use of neoadjuvant endocrine therapy.Disruption of the ER-α36-EGFR/HER2 positive regulatory loops restores tamoxifen sensitivity in tamoxifen resistance breast cancer cells Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance Therapeutic Considerations in Treating HER2-Positive Metastatic Breast Cancer Downregulation of ER-α36 expression sensitizes HER2 overexpressing breast cancer cells to tamoxifen The role of Herceptin in early breast cancer Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells HER story: the next chapter in HER-2-directed therapy for advanced breast cancer.Outcomes following adjuvant therapy for HER2-positive early breast cancer in the elderly.Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer Mode of action of pertuzumab in combination with trastuzumab plus docetaxel therapy in a HER2-positive breast cancer xenograft model.A monoclonal antibody as an effective therapeutic agent in breast cancer: trastuzumab.Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance.

P2860

Q33925038-F86A8083-94C7-4765-8FC1-86D94D3134DF Q34156192-0532D2AF-6FEA-4DBB-96AB-3DE25C1A0F08 Q34164930-77E2C595-A892-4CB0-9149-B2951F17F145 Q34268618-8BD3C517-C52C-4E2F-904D-36D1A7BE8A22 Q35402408-B53A1130-3051-4BDF-BE3E-30F61CE624A2 Q36657407-543987E5-8155-4722-BA9A-615949FE812C Q36673777-4211E79D-6179-4BBF-AFF6-0B3BE57E858B Q37301435-4BB61B5E-E2A0-449B-BE8C-E1D77FB6CC86 Q37782094-875A2A0C-F08B-4326-8DCD-E5D1174D42AB Q41592633-558B42F5-8832-42E3-A643-6157969C06D8 Q41676872-028C4A4D-57F3-4C4C-BCB7-BA01AB391E36 Q46543444-9871EA0A-9E3E-4956-A69C-B9DA210E171C Q54610139-832B5C45-74F7-4927-B8F8-19CD340A25C8

P2860

Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2.

http://www.wikidata.org/entity/Q36620845

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Anti-HER2 antibody enhances th ...... oestrogen receptors and HER2.

@ast

Anti-HER2 antibody enhances th ...... oestrogen receptors and HER2.

@en

type

label

Anti-HER2 antibody enhances th ...... oestrogen receptors and HER2.

@ast

Anti-HER2 antibody enhances th ...... oestrogen receptors and HER2.

@en

prefLabel

Anti-HER2 antibody enhances th ...... oestrogen receptors and HER2.

@ast

Anti-HER2 antibody enhances th ...... oestrogen receptors and HER2.

@en

P1433

Q36620845-9119CCB7-EE9F-42A4-8E76-983D5C6C9174

P1476

Q36620845-B0F3EFDD-21CA-4B08-8495-226C37DD87B6

P2093

Q36620845-102B2A85-BC08-4816-8CCF-D4803BC560E5

Q36620845-11E20A5D-5752-4ACD-BDC5-6D7160F8C61F

Q36620845-1F4C7648-9A7B-416B-8DC1-58A100B446E8

Q36620845-4388D6DB-97D9-4162-AAD3-7AEBEE2B0681

Q36620845-74369D40-3F66-48AB-BA3D-E0396FC0DF37

Q36620845-7DCE1DA9-E630-4958-9790-9A1056415196

Q36620845-8621EF33-8543-4DF0-9384-839FEFEE810C

Q36620845-B7BD6D6B-BEE6-4FA7-8EE3-8ABC689B2BA5

Q36620845-ED36579E-63B3-4179-AA86-BC9A4014AB4B

Q36620845-FE3351A6-2D80-43B8-9DC1-1B4E7FF300FD

P2860

Q36620845-1EE4039B-978D-4B7C-949F-69635B414E57

Q36620845-2BB1878B-7FD4-44E4-8C16-8A6D65E22359

Q36620845-2DDF0839-88D7-411D-B099-184A4D2DA713

Q36620845-2E409CC7-D702-4401-956A-D1E19A96388C

Q36620845-2EDA2807-2B10-4FDC-9921-1A2D4D2C6877

Q36620845-311D8029-EADA-4234-BF55-46CD4B39062A

Q36620845-3E82FD75-2092-4501-81CF-AA4793AC23B7

Q36620845-421BA18C-FF16-4DF0-A2F5-4A8B374F1AFD

Q36620845-621A1369-9F8B-453C-89D1-198A9ECEFAA7

Q36620845-655B2009-45EC-45BF-8B10-F4DB0F27974E

P2888

Q36620845-E73C5F2B-D41F-4283-B858-267F581C4E31

P304

Q36620845-582CD0AD-A49E-4555-9E64-05A6D8675A6F

P31

Q36620845-369405DC-F32F-4FEA-ACF9-F02F03E595E7

P356

Q36620845-9FF210D4-22A9-46A4-8931-B3D2CCDDEE9E

P407

Q36620845-9F274924-92F3-4E80-A778-8AD9AC1CBB67

P433

Q36620845-C11A60CC-6622-4946-956D-DA02AF932FA0

P478

Q36620845-AAF359BA-2460-4414-99C1-346FF197BA08

P577

Q36620845-422B5E88-0056-4066-9DB0-DF9CA48A0287

P5875

Q36620845-969EFBD7-11F0-48B3-9AF0-62877F882DED

P6179

Q36620845-D3979C3E-7503-44EA-9DC0-C3AEA3B1D0D8

P698

Q36620845-C36362DD-9640-40C1-9F61-8042078054BB

P932

Q36620845-ACC36617-E25F-4740-B2A4-B9049EC3B344

P356

P1433

British Journal of Cancer

P1476

Anti-HER2 antibody enhances th ...... oestrogen receptors and HER2.

@en

P2093

C K Tang

http://www.w3.org/2001/XMLSchema#string

H Doihara

http://www.w3.org/2001/XMLSchema#string

H Kunisue

http://www.w3.org/2001/XMLSchema#string

H Sonoo

http://www.w3.org/2001/XMLSchema#string

J Kurebayashi

http://www.w3.org/2001/XMLSchema#string

K Tanaka

http://www.w3.org/2001/XMLSchema#string

M Kurosumi

http://www.w3.org/2001/XMLSchema#string

N Shimizu

http://www.w3.org/2001/XMLSchema#string

S Yamamoto

http://www.w3.org/2001/XMLSchema#string

T Otsuki

http://www.w3.org/2001/XMLSchema#string

P2860

Humanization of an anti-p185HER2 antibody for human cancer therapy

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.

Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6.

Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.

The neu (c-erbB-2) oncogene.

In vitro and in vivo anti-tumour effects of a humanised monoclonal antibody against c-erbB-2 product.

A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.

Human myeloma cell apoptosis induced by interferon-alpha.

P2888

P304

46-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.1999.0875

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12675446

http://www.w3.org/2001/XMLSchema#string

P6179

1023454472

http://www.w3.org/2001/XMLSchema#string

P698

10638965

http://www.w3.org/2001/XMLSchema#string

P932

2363211

http://www.w3.org/2001/XMLSchema#string